We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Preliminary Anti-tumour Activity of mTor Kinase Inhibitor in Advanced Tumours

This study has been withdrawn prior to enrollment.
(Amendment to study compound development programme)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01194193
First Posted: September 2, 2010
Last Update Posted: May 16, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
AstraZeneca
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: No date given
  Primary Completion Date: No date given